biote (NASDAQ:BTMD – Get Free Report) announced its earnings results on Wednesday. TD Cowen reissued a “buy” rating on shares of biote in a research report on Friday. Rothschild Wealth LLC acquired a new position in shares of biote in the 4th quarter valued at $380,000. Finally, Man Group plc boosted its holdings in biote by 419.1% in the second quarter. biote Company Profile(Get Free Report)biote Corp. operates in practice-building business within the hormone optimization space.